Correlation Between Spyre Therapeutics and Microbot Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Microbot Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Microbot Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Microbot Medical, you can compare the effects of market volatilities on Spyre Therapeutics and Microbot Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Microbot Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Microbot Medical.

Diversification Opportunities for Spyre Therapeutics and Microbot Medical

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Spyre and Microbot is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Microbot Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microbot Medical and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Microbot Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microbot Medical has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Microbot Medical go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Microbot Medical

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Microbot Medical. In addition to that, Spyre Therapeutics is 1.26 times more volatile than Microbot Medical. It trades about -0.02 of its total potential returns per unit of risk. Microbot Medical is currently generating about 0.08 per unit of volatility. If you would invest  89.00  in Microbot Medical on August 30, 2024 and sell it today you would earn a total of  8.00  from holding Microbot Medical or generate 8.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Spyre Therapeutics  vs.  Microbot Medical

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Microbot Medical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Microbot Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Spyre Therapeutics and Microbot Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and Microbot Medical

The main advantage of trading using opposite Spyre Therapeutics and Microbot Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Microbot Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will offset losses from the drop in Microbot Medical's long position.
The idea behind Spyre Therapeutics and Microbot Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements